It is therefore of great interest to examine the potential role of overexpressed HAPLN1 as a matrikine, rather than an ECM structural element, in other cancer types and whether these malignancies also employ a CH60/TLR4 complex to detect a HAPLN1 matrikine to promote pro-tumorigenic properties. The gene discussed is HAPLN1; the disease is cancer.